K76.0
Conditions
Interventions
Group 1: 1) Recording the overall quality of life in NAFLD patents: Chronic Liver Disease Questionnaire (CLDQ-NAFLD)
2) Detection of anxiety and depression:
Hospital Anxiety and Depression Scale (HAD
Sponsors
Universitätsklinikum Leipzig, Klinik für Gastroenterologie
Eligibility
Sex/Gender
All
Age
18 Years to 100 Years
Inclusion criteria
Inclusion criteria: 1) Age >18 years 2) Written informed consent 3) Clinical diagnosis of nonalcoholic fatty liver disease
Exclusion criteria
Exclusion criteria: 1) Participation in a clinical trial for the treatment of NAFLD 2) Existence of additional liver disease other than NAFLD 3) Alcohol consumption >30 g / d in men or >20 g / d in women 4) Language barrier with limited knowledge of German 5) Presence of hepatocellular carcinoma 6) Organ transplant recipient 7) Pregnancy and breastfeeding 8) Liver cirrhosis Child B or Child C
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| How common are anxiety, depression and pruritus in non-selected NAFLD patients? | — |
Secondary
| Measure | Time frame |
|---|---|
| What is the overall quality of life in non-selected NAFLD patients? What are the interactions between anxiety, depression and pruritus and general quality of life? Do anxiety, depression and pruritus correlate with clinical parameters (e.g. the extent of sonographically measured liver stiffness (transient elastography, fibroscan®) as a surrogate parameter of hepatic fibrosis)? | — |
Countries
Germany
Contacts
Public ContactClaudia Breithaupt
Universitätsklinikum Leipzig, Klinik für Gastroenterologie
Outcome results
None listed